Skip to main content
GENESIS IBRC INDIA LIMITED logo

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings

Ticker · 514336 ISIN · INE194N01016 BSE.NS Manufacturing
Open in API
Filings indexed 311 across all filing types
Latest filing 2024-08-14 Board/Management Inform…
Country IN India
Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing Released Lang Actions
Outcome of the Board Meeting held on 14.08.2024
Board/Management Information Classification · 95% confidence The document is a formal communication from Genesis IBRC India Limited to the BSE Limited corporate relations department. It reports the outcome of a Board Meeting held on August 14, 2024. The key points include approval of unaudited financial results for the first quarter ended June 30, 2024, scheduling of the 32nd Annual General Meeting, and reappointments of directors subject to member approval at the AGM. The document also includes brief profiles of the directors being reappointed. The content focuses on board decisions and management changes rather than presenting full financial statements or detailed financial analysis. It is not a full quarterly report (IR) or annual report (10-K), nor is it a call transcript or earnings release. The primary purpose is to announce board meeting outcomes and management appointments. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (6230 characters) supports it being a detailed announcement rather than a brief notice or report publication announcement.
2024-08-14 English
Genesis Ibrc India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve With reference to the subject ....
Regulatory Filings Classification · 95% confidence The document is a notice from Genesis IBRC India Limited informing the Bombay Stock Exchange about a scheduled Board Meeting to be held on August 14, 2024. The purpose of the meeting includes consideration and approval of the unaudited financial results for the first quarter ended June 30, 2024. The document references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document is a notification of an upcoming board meeting and not the actual financial report or results. It is short (1302 characters) and serves as an announcement rather than containing substantive financial data or analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2024-08-06 English
Certificate under 74(5)
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June 2024. It is a compliance certificate related to dematerialisation of securities and updating records with depositories and stock exchanges. The document is short (2795 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2024-07-13 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Corporate Relations Department of BSE Limited, dated 27.06.2024, from Genesis IBRC India Limited. It announces the closure of the trading window for insiders and their relatives from 1st July 2024 until 48 hours after the declaration of the audited financial results for the first quarter ended 30th June 2024. The letter references compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The document does not contain any financial data or results itself, nor does it present a report. Instead, it is an announcement related to insider trading restrictions ahead of the financial results announcement. This type of communication is regulatory in nature and does not fit into categories like earnings release or interim report. It is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement to the stock exchange without substantive financial content.
2024-06-27 English
Disclosure under Regulation 32
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Corporate Relations Department of BSE Limited, dated 29.05.2024, disclosing information under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It states that the regulation is not applicable as the company has not raised any funds and hence no annexure is submitted. This is a regulatory disclosure related to compliance with SEBI regulations, specifically about deviation or variation in proceeds from fundraising activities, but no actual fundraising or capital change has occurred. The document is short (1339 characters) and serves as a regulatory compliance announcement rather than a financial report or capital update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-29 English
Submission of results
Regulatory Filings
2024-05-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.